The incidence of pulmonary immune related adverse events in serial [18F]-FDG-PET/CT is not correlated to pulmonary metastasation or intrapulmonary tumor volume but potentially to therapy response in patients treated with immunotherapy
Journal title abbreviation:
J Nucl Med
Year:
2020
Journal volume:
61 Suppl 1
Print-ISSN:
0161-5505
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)